Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Directors Deals Ltd.
$12.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chr Hansen Holding A/S Comments On FY 2012/2013 Organic Growth Guidance and EBIT Margin Guidance


Wednesday, 3 Jul 2013 02:00am EDT 

Chr Hansen Holding A/S announced that for the fiscal year 2012/2013, it has decided to narrow its expectation to organic growth excluding carmine price effect to between 8% and 9%. In addition, organic growth including carmine price effect is now expected to be in the range of between 6% and 7%. EBIT margin before special items and impairments is now expected to be around 27%. 

Company Quote

274.2
1.1 +0.40%
23 Dec 2014